Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of time-of-day effects on Hepatitis B vaccine immune response in health-care students
2014-003756-32Phase 4Terminated
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Mar 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of hepatitis B vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Feasibility of procedures for definitive circadian rhythm study of vaccine responses. Started Mar 2019; status: terminated.
02
Drugs
hepatitis B vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2014-003756-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003756-32.